Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Pharmacodynamic models for discrete data.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
[Spinal anesthesia for cesarean section in a patient with multiple sclerosis].
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis].
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.
Cognitive rehabilitation in Multiple sclerosis.
Assessment of visual disability using visual evoked potentials.
Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
Iron in multiple sclerosis: roles in neurodegeneration and repair.
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
Neuroscience. To learn is to myelinate.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Nrf2 in health and disease: current and future clinical implications.
Fingolimod induces neuroprotective factors in human astrocytes.
Bilateral idiopathic optic neuritis in pregnancy.
Brain size and white matter content of cerebrospinal tracts determine the upper cervical cord area: evidence from structural brain MRI.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Pages
« first
‹ previous
…
213
214
215
216
217
218
219
220
221
…
next ›
last »